- EQS-PVR: MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-News: MorphoSys AG Reports First Quarter 2024 Financial Results
- EQS-News: MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
- EQS-News: MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
- EQS-NVR: MorphoSys AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-News: MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
More ▼
Key statistics
As of last trade MorphoSys AG (MOR:NSQ) traded at 18.60, -4.64% below its 52-week high of 19.50, set on May 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.72 |
---|---|
High | 18.75 |
Low | 18.52 |
Bid | 18.59 |
Offer | 18.60 |
Previous close | 19.00 |
Average volume | 407.33k |
---|---|
Shares outstanding | 150.87m |
Free float | 126.33m |
P/E (TTM) | -- |
Market cap | 2.84bn USD |
EPS (TTM) | -3.41 USD |
Data delayed at least 15 minutes, as of May 20 2024 20:18 BST.
More ▼